Zoetis Faces Investor Lawsuit After 21% Stock Plunge—What Shareholders Need to Know Now
New York, Thursday, 18 June 2026.
Zoetis, a leader in animal health, is hit with a securities fraud lawsuit after its stock dropped 21.5% in a single day. Investors who bought shares between January 2025 and May 2026 allege the company misled them about key products like Librela, facing FDA safety warnings, and market share losses to competitors. With a July 27 deadline to join the lawsuit, affected shareholders must act fast. The case could reshape investor trust in pharmaceutical and animal health sectors amid regulatory scrutiny.